About Recues Biosciences
Recues Biosciences is a Healthcare company based in Bengaluru (India) founded in 2018 by Vignesh Subramanian and Sridhar Haranahalli. It develops innovative technologies in regenerative medicine for healthcare applications. It operates on a B2B model. Its Indian entity Recues Biosciences Private Limited reported revenue of ₹1.39 Cr. Its focus areas include Biotechnology, Regenerative Medicine and Technology Development.
Company details
Recues Biosciences operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, regenerative medicine, and technology development. Develops innovative technologies in regenerative medicine for healthcare applications. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Bengaluru, India
- Founders Vignesh Subramanian, Sridhar Haranahalli
- SectorsHealthcare
- Email••••••••
- Website recuesbio.com
- Legal Name Recues Biosciences Private Limited
- Date of Incorporation 28 Sep, 2018
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹1.39 Cr
FY 2024 · +46% YoY
- Net Profit₹13.4 Lakh
FY 2024 · 10% margin
- EBITDA₹16.3 Lakh
FY 2024 · 12% margin
Associated legal entities of Recues Biosciences
Recues Biosciences operates through Recues Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Recues Biosciences Private Limited CIN U74996KA2018PTC116990 | Active | 28 Sep 2018 | Bangalore, Karnataka | ₹1.4 Cr | 3 | View details |
Board of directors of Recues Biosciences Private Limited (Recues Biosciences)
Recues Biosciences Private Limited is the primary company behind Recues Biosciences. The board of Recues Biosciences Private Limited currently have 3 directors; the longest-serving is Tiptur Rangaswamy Manjunath, appointed in 2018.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tiptur Rangaswamy Manjunath DIN 08241747 | Director | 28 Sep 2018 | 8 yrs 1 mo | Recues Biosciences Private Limited |
| Manjunath Pooja DIN 08241748 | Director | 28 Sep 2018 | 8 yrs 1 mo | Recues Biosciences Private Limited |
| Vignesh Subramanian DIN 08241749 | Director | 28 Sep 2018 | 8 yrs 1 mo | Recues Biosciences Private Limited |
People of Recues Biosciences
2 people are tracked at Recues Biosciences (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
Sridhar Haranahalli | Co-Founder | Leadership |
Complete people profiles for Recues Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Recues Biosciences
Figures of Recues Biosciences Private Limited, the primary company behind Recues Biosciences, for FY 2024. Revenue was ₹1.39 Cr (+46% year on year). Net profit was ₹13.4 Lakh (10% margin). EBITDA was ₹16.3 Lakh (12% margin). Revenue has grown at a compounded annual rate of +90% over three years and +346% over five years.
- ₹1.39 CrRevenue · FY 2024 · +46% YoY
- ₹13.4 LakhNet profit · 10% margin
- ₹16.3 LakhEBITDA · 12% margin
- ₹2 LakhPaid-up capital
- +90%Revenue CAGR, 3 years
- +346%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Recues Biosciences Private Limited are on its company page.
Detailed financial statements for Recues Biosciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
2 companies that operate in the same segment as Recues Biosciences (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | USD 50.52 M | 902 | ||
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | USD 4.22 M | 228 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Recues Biosciences
Recues Biosciences was founded in 2018.
Recues Biosciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
The primary company behind Recues Biosciences, Recues Biosciences Private Limited, reported revenue of ₹1.39 Cr for FY 2024, up 46% year on year.
Recues Biosciences operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, regenerative medicine, and technology development. Develops innovative technologies in regenerative medicine for healthcare applications. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Recues Biosciences operates through Recues Biosciences Private Limited.
The legal entities of Recues Biosciences currently have 3 directors, including Tiptur Rangaswamy Manjunath, Manjunath Pooja, Vignesh Subramanian.